Another poster mentioned Hikurangi over here in NZ as a...

Another poster mentioned Hikurangi over here in NZ as a possibility ...my apologies as I couldn't find the post, but I have attached an article from our local newspaper two nights ago over here in Gisborne NZ about their fundraising attempts....perhaps it is this?

Million-dollar local backing

Region digs deep to invest in cannabis venture.

Families in New Zealand's poorest region have just invested a million dollars in medical cannabis.
Families in New Zealand’s poorest region have invested more than a million dollars in medical cannabis.

Over the past week, East Coast communities have invested in a new regional fund established by charitable company Hikurangi Enterprises.
More than 550 people have so far committed $1,035,000 to purchase shares in Waiapu Investments Limited.
“If the Government is looking for local skin in the game before offering support to provincial economic development initiatives, then hopefully this level of support demonstrates local commitment,” said Waiapu Investments managing director Panapa Ehau.
“We have been blown away with the hundreds of people, young and old, from Potaka to Gisborne, who have put their own money into something we hope will benefit the whole region,” he said.
The first investment for the company is intended to be Hikurangi Cannabis Company, a Ruatoria-based medical cannabis venture established by Mr Ehau and others.
Interest from around the country and overseas is high, with more than three thousand people waiting for a chance to buy shares when the offer opens online at 7pm tomorrow on the PledgeMe crowdfunding website.
“It feels so special to have more than a million invested by our local people,” said Mr Ehau.
Sixty percent of the funds were raised at five rural village meetings before the roadshow arrived in Gisborne yesterday.
The funds contributed will enable the building of an extraction lab, processing facility and state-of-the-art glasshouses at Ruatoria, as soon as a licence is issued by the Ministry of Health.
“We are also talking to larger investors who are interested in coming into Waiapu Investments, so as much ownership as possible can be kept local,” said Mr Ehau.
“The more ownership residing in Waiapu Investments, the greater leverage we will have when negotiating with institutional investors — but the window won’t stay open very long.”
Mr Ehau said people and entities with more than $50,000 to invest should contact him as soon as possible to discuss the opportunities.
A separate process of selecting an institutional investor to partner in the cannabis company with $4m to $10m has been started by Auckland investment brokers Northington Partners.
The Hikurangi cannabis opportunity has already attracted interest from a number of potential investors with significant agribusiness experience, including companies from Asia and North America.
“Our preference is to find a New Zealand partner but we will also be looking at who can help us grow quickly into key export markets, support us to produce affordable medicines and build a global pharmaceuticals brand in an industry already booming in Europe and North America,” said Mr Ehau.